APA (7th ed.) Citation

HM, O., AP, G., MB, P., M, H., WS, H., AM, H., . . . MT, M. (2014). A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation. Molecular cancer therapeutics, 13(12), 3062. https://doi.org/10.1158/1535-7163.MCT-13-0876

Chicago Style (17th ed.) Citation

HM, Ott, et al. "A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation." Molecular Cancer Therapeutics 13, no. 12 (2014): 3062. https://doi.org/10.1158/1535-7163.MCT-13-0876.

MLA (9th ed.) Citation

HM, Ott, et al. "A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation." Molecular Cancer Therapeutics, vol. 13, no. 12, 2014, p. 3062, https://doi.org/10.1158/1535-7163.MCT-13-0876.